Business Standard

Abbott India rises after strong Q1 dose

Image

Capital Market

Abbott India gained 2.76% to Rs 8836.8 at 13:51 IST on the BSE after net profit jumped 41.91% to Rs 116.94 crore on 18.22% rise in net sales to Rs 998.89 crore in Q1 June 2019 over Q1 June 2018.

The result was announced during the market hours today, 8 August 2019.

Meanwhile, the S&P BSE Sensex was up by 216.5 points or 0.59% at 36,907.

On the BSE, 813 shares were traded in the counter so far compared with average daily volumes of 431 shares in the past two weeks. The stock had hit an intraday high of Rs 8850.1 and an intraday low of Rs 8579.65 so far during the day. The stock hit a 52-week high of Rs 8998.95 on 1 July 2019 and a 52-week low of Rs 6900 on 26 October 2018.

 

Abbott India is one of the largest MNC pharma companies operating in India. The company is engaged in the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company also has its presence in both OTC drugs and formulations.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 08 2019 | 2:00 PM IST

Explore News